Form 8-K - Current report:
SEC Accession No. 0001193125-21-311373
Filing Date
2021-10-28
Accepted
2021-10-28 16:32:12
Documents
13
Period of Report
2021-10-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d245532d8k.htm   iXBRL 8-K 31491
2 EX-99.1 d245532dex991.htm EX-99.1 9898
  Complete submission text file 0001193125-21-311373.txt   174169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sttk-20211022.xsd EX-101.SCH 2905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20211022_lab.xml EX-101.LAB 18889
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20211022_pre.xml EX-101.PRE 11869
6 EXTRACTED XBRL INSTANCE DOCUMENT d245532d8k_htm.xml XML 3518
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 211358794
SIC: 2834 Pharmaceutical Preparations